Kamada Ltd.
- Address
- 2 Holzman Haim Street
Sponsor Overview
Specializations
Alpha-1 Antitrypsin Deficiency
Kamada Ltd. is engaged in clinical research for adults with congenital alpha-1 antitrypsin deficiency, with attention to patients who have moderate to severe airflow limitation and reduced pulmonary function.
- Congenital alpha-1 antitrypsin deficiency
- Adult respiratory disease
- Pulmonary function impairment
The sponsor’s research focus in this area centers on chronic lung disease associated with inherited protein deficiency.
Chronic Obstructive Pulmonary Disease
The clinical programme also addresses COPD-related airway limitation in a population selected for stable disease without frequent recent exacerbations, reflecting interest in long-term respiratory management.
- Airflow limitation
- Bronchodilator response
- Chronic respiratory impairment
This area aligns with therapeutic development for persistent obstructive pulmonary conditions.
Inhalation Therapy
Kamada Ltd. is active in research involving inhaled therapy for respiratory disease, with an emphasis on targeted delivery to the airways and maintenance treatment over an extended period.
- Inhaled protein replacement
- Airway-targeted treatment
- Long-term respiratory therapy
The company’s therapeutic interest includes treatments designed for chronic administration in pulmonary medicine.
Respiratory Function Assessment
Its research landscape includes clinical evaluation of lung function in patients with inherited respiratory disease, with attention to measures of expiratory performance and airway obstruction.
- FEV1
- Forced expiratory assessment
- Airflow mechanics
This reflects a strong interest in objective respiratory endpoints relevant to chronic obstructive disease management.
Multicenter Respiratory Research
The sponsor supports multicenter clinical research across several countries, indicating activity in internationally coordinated studies focused on rare respiratory disorders.
- International study networks
- Rare disease research
- Specialist pulmonary sites
Its clinical interests are concentrated in specialty respiratory care for inherited and chronic obstructive lung disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety of Human Alpha1-Proteinase Inhibitor Inhalation in Adults with Congenital Alpha-1 Antitrypsin Deficiency and Moderate to Severe Airflow Limitation |  Belgium Finland Ireland Sweden The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 6 sites across their trial portfolio.
Therapeutic Focus
- 1.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
6 centres- Address
- Beaumont Road, Beaumont, D09 V2N0 Dublin
- Address
- Weg Door Jonkerbos 100, 6532 SZ Nijmegen
- Address
- Herestraat 49, 3000 Leuven
- Address
- Albinusdreef 2, 2333 ZA Leiden
- Address
- Elamanaukio 2, 33520 Tampere
- Address
- Jan Waldenstroms Gata 15, Malmo St Johannes, 214 28 Malmö
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Kamada Ltd..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.